|
HS Code |
364451 |
As an accredited 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every experienced chemist recognizes how selecting the right molecular scaffold can shape the outcome of an entire research project. Laboratory work seldom rewards shortcuts or cheap imitations. The compound 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine stands out for researchers who want to work with a reliable, specific pyrazolopyrimidine platform, making it a practical choice for both small-scale proof-of-concept experiments and more ambitious synthesis efforts.
3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine brings a unique fusion of bromine and amine functionalities onto a fused pyrazolopyrimidine core. This molecule captures the attention of medicinal chemists and development scientists alike, given its ability to facilitate targeted chemical modifications. I’ve seen firsthand how its structure supports stepwise substitution reactions without the unpredictability that frustrates progress in some other heterocyclic systems. The precision in its arrangement means researchers often trust it as a springboard for new kinase inhibitor candidates, anti-inflammatory leads, or other bioactive molecules.
Synthetic chemistry hinges on the availability of reactive, scaffolded platforms that can reliably absorb further structural changes. 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine offers several clear advantages here. The bromine atom introduces a handle for cross-coupling chemistry, with widely known Suzuki or Buchwald-Hartwig reactions offering robust routes to diversify the core. Unlike some other pyrimidine analogs, the presence of both a bromine at the 3-position and an amine at the 4-position gives a rare convergence of functional groups that allows flexible, sequential modifications instead of forcing a fixed synthetic sequence. For myself and my colleagues, this often saves days or even weeks in a campaign where synthetic pathways otherwise stall. Such real-life observations shape a chemist’s confidence in this scaffold for rapid analog generation.
Pyrazolopyrimidines come in many flavors. Some lack halogenation, limiting their value in modern cross-coupling work. Others bear different substituents that crowd reactive sites or complicate further elaboration. Among the available candidates, the 3-bromo variant with an NH2 at the 4-position maintains a careful balance: it provides both reactivity and selectivity, without introducing major instability or lability that can frustrate batch-to-batch reproducibility. In my lab, trying to force similar chemistry onto scaffolds with chlorine (rather than bromine) or onto monosubstituted pyrimidines rarely gave such predictable positive outcomes. Monohalogenated systems with a neighboring amine often revealed sluggish reaction kinetics or side-reactions that waste precious starting material.
Most often, 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine turns up in lead discovery projects. Drug design teams lean on it as a privileged structure, especially where kinase inhibition offers a promising biological route. Literature highlights its use in libraries targeting signal transduction disorders and certain inflammation-driven pathways, due to the tractable nature of this core and evidence that pyrazolopyrimidine derivatives interact favorably with ATP-binding sites. The compound’s amine handle takes well to functionalization, expanding its chemical diversity and giving chemists room to optimize for potency, selectivity, or metabolic stability.
Beyond medicinal chemistry, some research groups apply this scaffold in agrochemical screens, aiming to identify molecules that tweak specific plant or pest pathways. Not every system responds to a single scaffold equally, but the relative ease of tailoring the pyrazolopyrimidine’s side chains keeps researchers interested. For emerging applications—like development of imaging agents or molecular probes—3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine serves as a practical starting point because it supports attachment of chemical reporters or bioconjugates.
Colleagues often ask whether a compound that delivers so much reactivity can also withstand normal laboratory handling. Through years of bench experience, I’ve found this molecule reasonably robust under ambient conditions, showing none of the air- or moisture-sensitivity that plagues some nitrogen-rich scaffolds. Purification, whether by column or crystallization, rarely presents the headaches seen with more polar or delicate frameworks. The bromine moiety does require care during some reductive or oxidative steps, yet routine protection strategies ensure survival through standard work-ups.
On the synthetic front, producing 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine in high yield relies on access to quality starting materials, particularly a pyrazolopyrimidine intermediate correctly positioned for electrophilic bromination. Many commercial sources report batch-tested quality; those aiming to synthesize it themselves can follow published routes using well-documented procedures and common laboratory glassware. This ease of access stands in contrast to some other heterocycles that demand tricky or expensive reagents, often a non-starter for small labs or budget-constrained teams.
No synthetic tool is perfect, and real-world hurdles do crop up. A recurring one centers on the quality and freshness of starting pyrazolopyrimidine cores; impurities creep in during storage and can lower yields. Routine TLC checks and proper storage in cool, dry conditions go a long way toward keeping the chemistry on track. Another bottleneck stems from cross-coupling: even with a bromine, poor palladium source or insufficient base can leave unconverted starting material behind. I tend to favor robust ligands and freshly prepared catalysts, drawing from the experiences of seasoned colleagues who have tested these reactions at both small and preparative scales. Documentation in peer-reviewed journals confirms these workarounds and best practices.
Handling the amine moiety invites its own quirks—sometimes, protection with a simple Boc or acetyl group shields the site through a tricky transformation, unlocking smoother downstream work. Patience and vigilance, along with savvy technique, often separate a smooth workflow from wasted bench time. Fellow chemists periodically find the solubility in certain organic solvents a limitation during batch upscaling, though small adjustments to solvent systems or temperature usually clear this up.
Trust in a chemical rests largely on reproducibility. Published NMR, LC-MS, and melting point values for 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine make comparison and verification straightforward. Analytical chemists running batch intake in my workplace routinely confirm identity and purity using these benchmarks—impurities, if present, reveal themselves quickly. By aligning sourcing habits with suppliers who publish up-to-date quality control reports, users steer clear of subpar lots, reducing wasted time on debugging preventable synthetic failures.
Access to third-party analytical data builds confidence, letting research teams quickly move from intake to application. If a compound falls outside specification, replacement or resynthesis is quicker with clear standards and strong vendor communication. For teams in regulated environments, such as those working toward clinical candidate nomination, audit-friendly records and batch traceability count for even more. In my experience, establishing a habit of confirming critical data upfront pays dividends during high-pressure deadlines or regulatory reviews.
Selecting this molecule over less-characterized alternatives represents more than just technical preference. Good laboratory practice and scientific transparency demand that researchers use well-described, reproducible starting points for their discoveries. Stakeholders from funding bodies to pharmaceutical companies and, crucially, the public, expect these choices to lead to reliable evidence. Scientists familiar with past cases of ambiguous biological results tied to off-spec chemical inputs know that starting with a well-studied molecule—clearly characterized, sourced responsibly—marks the wise path, not merely the convenient one.
From my perspective, learning from both personal projects and published case studies, using a thoroughly vetted scaffold like 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine contributes to a culture of integrity and accountability in research. Not every lab enjoys unlimited resources, but decisions based on solid experience and sound external evidence reduce the risk that time and intellectual effort will unravel over a mischaracterized batch.
The pipeline for kinase-targeted drugs and other signal-interrupting agents continues to drive demand for heterocyclic building blocks that marry versatility with proven biological relevance. As teams generate new generations of inhibitors, chemical biology probes, or agrochemical candidates, they keep returning to reliable scaffolds that absorb structural change without unpredictability. In my own work, I’ve found that staying current with literature and engaging with peers uncovers nuanced improvements in reaction conditions and transformation strategies for 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine, leaving room for better yields or access to novel chemical space.
Postdoctoral researchers and graduate students now have a richer foundation of published protocols and troubleshooting tips than ever before. Many share their adaptations and lessons learned through open-access journals or online forums, keeping the community informed about incremental improvements. Among the lessons echoed in most discussions: start with reproducibly pure precursors, validate all steps at scale, and remain open to informed course correction. Each successful round of analog generation feeds back into the ecosystem, allowing everyone from seasoned medicinal chemists to undergraduate researchers to benefit from a proven, tractable chemical starting point.
Training the next wave of chemists relies as much on choice of building block as on technique. Scaffolds that behave predictably help students develop troubleshooting skills and creative problem-solving habits. I’ve overseen project-based classes where teams constructed complex analogs from 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine and saw firsthand that reliable intermediates encourage deeper learning, faster iteration, and greater enthusiasm. The molecule’s well-documented reactivity and flexibility foster a sense of progress, while its quirks nudge students to hone careful work habits and pay close attention to reaction monitoring and purification.
Educators can point to published spectra and transformation comparisons in the literature, sparking discussions about structure-reactivity relationships, coupling efficiency, and the influence of substituents. As science education shifts to embrace real-world problem solving, having a versatile, characterizable chemical platform like this one gives future chemists room to practice and grow, without the stumbling blocks of obscure impurities or capricious reaction profiles.
Work with 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine raises standard issues in chemical handling: safe disposal of halogenated waste, responsible purchasing practices, and protecting students and staff from overexposure. In my own lab, we rely on fume hoods for all manipulations, institute thorough glove use and eye protection, and maintain clear protocols for bromine-containing liquids and residues. The chemistry supports most routine reactions without explosive risk, but teams benefit by maintaining rigorous chain-of-custody and spill response habits, as outlined in education and research safety guides.
With increased awareness of green chemistry metrics, some practitioners look for less hazardous alternatives or process modifications that minimize environmental burden. Solvent recycling, real-time monitoring for leaks, and micro-scale trials keep environmental impact controlled. Some innovative labs use flow chemistry to reduce exposure and automate purification, squeezing more efficiency and safety out of classic reactions while using this scaffold.
Scientific progress rarely arrives in isolation. Experts in analytical chemistry, process optimization, and bioassay development share insights that lead to better use of core building blocks such as 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine. In my own experience, joining interdisciplinary project groups amplifies creative solutions, from improving purity assessment methods to tweaking reaction timing and temperature for better yield. Core facilities trading protocols circumvent the inertia of working in silos and help teams overcome technical stumbles.
Social platforms, like preprint archives and collaborative notebook services, build an ecosystem for reporting both triumphs and technical snags. These environments benefit the broader community—mistakes surface quickly and suggested fixes get vetted faster. As the field continues to move toward open science, users of this scaffold and others like it stand to gain from a culture of transparency and mutual aid.
Success in both drug discovery and wider chemical development depends on a mixture of reliability and adaptability. 3-Bromo-1H-Pyrazolo[3,4-D]Pyrimidine-4-Amine has secured real-world value by offering predictable chemistry, diverse transformation routes, and widespread literature support for its use as both a lead molecule and an intermediate. Trust grows from experience—the kind logged by decades of collective experimentation, scrupulous documentation, and robust analytical confirmation.
Seasoned scientists and new students alike gravitate toward tools that let them spend time innovating, rather than troubleshooting. With a structure that keeps options open for both minor tweaks and bold new analogs, this compound earns its reputation as a reliable molecular platform for advancing research. Years spent at the bench reinforce that lesson: foundations matter, and molecules that support good science—both in their chemical properties and in the culture of open communication around their use—enable progress that stands up under real-world scrutiny.